NERRE THERAPEUTICS LTD

Active Stevenage

Research and experimental development on biotechnology

13 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
N

NERRE THERAPEUTICS LTD

Research and experimental development on biotechnology

Founded 19 Jan 2012 Active Stevenage, United Kingdom 13 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

MOFO FIFTY-ONE LIMITED 19 Jan 2012 — 14 Sept 2012
Accounts Submitted 26 Feb 2026 Next due 31 Mar 2026 22 days overdue
Confirmation Submitted 10 Mar 2026 Next due 1 Mar 2027 10 months remaining
Net assets £-23M £3M 2025 year on year
Total assets £2M £4M 2025 year on year
Total Liabilities £26M £956K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Stevenage Bioscience Catalyst Incubator Building Gunnels Wood Road Stevenage Hertfordshire SG1 2FX

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for NERRE THERAPEUTICS LTD (07916206), an active life sciences and medical technology company based in Stevenage, United Kingdom. Incorporated 19 Jan 2012. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2016–2025)

Cash in Bank

£2.23M

Decreased by £2.43M (-52%)

Net Assets

-£23.33M

Decreased by £2.87M (-14%)

Total Liabilities

£25.80M

Decreased by £956.21k (-4%)

Turnover

N/A

Employees

13

Decreased by 1 (-7%)

Debt Ratio

1043%

Increased by 618 (+145%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (9)

Investor NameInvestor SinceParticipating Rounds
Investor 4Dec 2012Series B, Series A
Investor 6Dec 2012Series A
Investor 7Dec 2012Series A

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 2,000,000 Shares £400.00m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
11 Dec 20152,000,000£400.00m£200

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Nerre Therapeutics Holdings Limited
100.0%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased

Advent Life Sciences Llp

Ceased 25 Jun 2021

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
31 Mar 2026OfficersTermination of Andrew Martin Kay as director on 2026-03-31
10 Mar 2026Confirmation StatementConfirmation statement made on 2026-02-15 with no updates
26 Feb 2026AccountsAnnual accounts made up to 2025-06-30
18 Feb 2026OfficersChange to director Dr Iain David Dukes on 2026-02-17
18 Feb 2026OfficersChange to director Dr Ena Prosser on 2026-02-18
31 Mar 2026 Officers

Termination of Andrew Martin Kay as director on 2026-03-31

10 Mar 2026 Confirmation Statement

Confirmation statement made on 2026-02-15 with no updates

26 Feb 2026 Accounts

Annual accounts made up to 2025-06-30

18 Feb 2026 Officers

Change to director Dr Iain David Dukes on 2026-02-17

18 Feb 2026 Officers

Change to director Dr Ena Prosser on 2026-02-18

Recent Activity

Latest Activity

Termination of Andrew Martin Kay as director on 2026-03-31

3 weeks ago on 31 Mar 2026

Confirmation statement made on 2026-02-15 with no updates

1 months ago on 10 Mar 2026

Annual accounts made up to 2025-06-30

1 months ago on 26 Feb 2026

Change to director Dr Iain David Dukes on 2026-02-17

2 months ago on 18 Feb 2026

Change to director Dr Ena Prosser on 2026-02-18

2 months ago on 18 Feb 2026